Author of the publication

Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma

, , , , , , , , , , , , , and . Cell Death & Disease, 11 (2): 124 (2020)
DOI: 10.1038/s41419-020-2309-3

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma, , , , , , , , , and 4 other author(s). Cell Death & Disease, (February 2020)Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma, , , , and . BMC Cell Biology, (2018)Examining the In Vitro Efficacy of the IAP Antagonist Birinapant as a Single Agent or in Combination With Dacarbazine to Induce Melanoma Cell Death, , , , , and . Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 25 (9): 1489--1494 (November 2017)Examining the In Vitro Efficacy of the IAP Antagonist Birinapant as a Single Agent or in Combination With Dacarbazine to Induce Melanoma Cell Death, , , , , and . Oncology research, 25 (9): 1489-1494 (2017)Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma, , , , and . BMC Cell Biology, 19 (1): 28 (December 2019)Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma, , , , , , , , , and 4 other author(s). Cell Death & Disease, 11 (2): 124 (2020)